1. Accelerated Approval of Anticancer Drugs: Lessons Learned From the Example of Olaratumab. Issue 1 (4th November 2020) Authors: Papachristos, Apostolos; Ratain, Mark J. Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 1(2021) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antibody-drug conjugates: a mini-review. The synopsis of two approved medicines. (12th June 2016) Authors: Papachristos, Apostolos; Pippa, Natassa; Demetzos, Costas; Sivolapenko, Gregory Journal: Drug delivery Issue: Volume 23:Number 5(2016:Jul.) Page Start: 1662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer. (28th April 2020) Authors: Papachristos, Apostolos; Kemos, Polychronis; Kalofonos, Haralabos; Sivolapenko, Gregory Journal: Oncologist Issue: Volume 25:Number 10(2020) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Direct oral anticoagulant considerations in solid organ transplantation: A review. Issue 1 (28th December 2016) Authors: Salerno, David M.; Tsapepas, Demetra; Papachristos, Apostolos; Chang, Jae‐Hyung; Martin, Spencer; Hardy, Mark A.; McKeen, Jaclyn Journal: Clinical transplantation Issue: Volume 31:Issue 1(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Do we need to adopt antifungal stewardship programmes?. Issue 1 (28th June 2018) Authors: Ioannidis, Konstantinos; Papachristos, Apostolos; Skarlatinis, Ioannis; Kiospe, Fevronia; Sotiriou, Sotiria; Papadogeorgaki, Eleni; Plakias, George; Karalis, Vangelis D; Markantonis, Sophia L Journal: European journal of hospital pharmacy Issue: Volume 27:Issue 1(2020) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. In Reply. (26th October 2020) Authors: Papachristos, Apostolos; Kemos, Polychronis; Kalofonos, Haralabos; Sivolapenko, Gregory Journal: Oncologist Issue: Volume 25:Number 12(2020) Page Start: e2023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Liposomal forms of anticancer agents beyond anthracyclines: present and future perspectives. (June 2015) Authors: Papachristos, Apostolos; Pippa, Natassa; Ioannidis, Konstantinos; Sivolapenko, Gregory; Demetzos, Costas Journal: Journal of liposome research Issue: Volume 25:Number 2(2015) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Machine learning‐guided covariate selection for time‐to‐event models developed from a small sample of real‐world patients receiving bevacizumab treatment. (4th August 2022) Authors: Karatza, Eleni; Papachristos, Apostolos; Sivolapenko, Gregory B.; Gonzalez, Daniel Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 11:Number 10(2022) Page Start: 1328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Quantifying self-rated age. (4th May 2022) Authors: Verropoulou, Georgia; Papachristos, Apostolos; Ploubidis, George B.; Tsimbos, Cleon Journal: Population studies Issue: Volume 76:Number 2(2022) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Subjective survival: An assessment of accuracy according to individual social profile. Issue 1 (2nd January 2020) Authors: Papachristos, Apostolos; Verropoulou, Georgia Journal: Communication in statistics Issue: Volume 6:Issue 1(2020) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗